A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma (Q61627994)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 September 2012
edit
Language Label Description Also known as
English
A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma
scientific article published on 01 September 2012

    Statements

    A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit